Background {#Sec1}
==========

Clinical interventions that lack efficacy, have risks that outweigh benefits, or are not cost-effective constitute low-value care \[[@CR1]\]. In the USA, overuse of low-value practices is estimated to cost upwards of 100 billion dollars annually \[[@CR2]\] and is associated with adverse events, poor patient outcomes, and downstream use of healthcare resources \[[@CR3], [@CR4]\]. Reducing low-value care is therefore imperative for high-quality, sustainable healthcare. Researchers, governments, and public campaigns have commanded attention about low-value care by classifying hundreds of tests and treatments as low-value \[[@CR5]--[@CR8]\]. Yet, this increased awareness about low-value care has not translated into a reduction in use \[[@CR9]--[@CR11]\]. The use of low-value care may be reduced or stopped through de-implementation, which is defined as a planned process that uses targeted strategies such as education, incentives, or audit and feedback \[[@CR12]\]. There is a need to understand how to achieve meaningful reduction in low-value care through comprehensive de-implementation interventions that acknowledge the complexity of this issue and appropriately engage researchers, decision-makers, clinicians, and patients.

Patients are directly involved in and impacted by low-value care and may play a pivotal role in solutions to reduce its use \[[@CR13], [@CR14]\]. However, the potential effects of patient engagement in de-implementation initiatives are complex. On the one hand, clinicians often cite patient demand for tests and treatments as a barrier to reducing low-value care \[[@CR15], [@CR16]\], while on the other hand, patients may experience mental and/or physical harm from unnecessary tests and treatments \[[@CR4]\]. Making this question even more complex is the fact that inclusion of patients within initiatives to reduce low-value care may impute a mistrust within the patient-clinician interaction and create a false sense of the ubiquity of low-value care within the practice of medicine, while this is indeed not the case \[[@CR2]\]. So, while it is assumed that patients should be engaged in any initiative that seeks to increase or decrease the use of clinical care, from the perspective of de-implementing low-value care, the risk/benefit ratio of such a patient-engagement strategy is not clearly defined, and a more thorough understanding is warranted before such a blanket recommendation. In a systematic review of interventions to reduce low-value care conducted in 2017, 26 of 108 included studies engaged patients within de-implementation interventions in some capacity (e.g., patient cost sharing, provider report cards) \[[@CR17]\]. While the authors summarized the effects of patient engagement as "positive" through a narrative synthesis, the effect of such patient engagement was not quantified through meta-analysis, making it difficult to understand the true magnitude of effect and how it compares to interventions that focus on clinicians. The full extent of the impact of patient engagement in de-implementation initiatives remains unclear. In this study, we conducted a systematic review with meta-analysis to determine the effects of de-implementation interventions that engage patients within the patient-clinician interaction and quantify the impact of this patient involvement on the use of low-value care.

Methods {#Sec2}
=======

Protocol and guidance {#Sec3}
---------------------

This systematic review and meta-analysis is a follow-up to a scoping review that mapped the literature exploring the public's role in reducing low-value care \[[@CR18]\], the protocol for which was registered with Open Science Framework (<https://osf.io/6fsxm>). Methodology was guided by the Joanna Briggs Institute Reviewer's Manual \[[@CR19]\], and the reporting was guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist \[[@CR20]\].

Search strategy and data sources {#Sec4}
--------------------------------

We searched MEDLINE, EMBASE, and CINAHL from inception to June 28, 2018, and the gray literature using the Canadian Agency for Drugs and Technologies in Health (CADTH) Grey Literature Search Tool \[[@CR21]\]. The search strategy was developed in consultation with a medical librarian and peer reviewed by a second medical librarian using the Peer Review of Electronic Search Strategies (PRESS) Checklist \[[@CR22]\]. The search strategy was initially developed in MEDLINE (Ovid) (Table [1](#Tab1){ref-type="table"}) and subsequently translated for EMBASE and CINAHL databases with the help of a medical librarian. Our search terms included keywords and synonyms pertinent to three main concepts: (1) low-value care (e.g., overuse, de-implementation), (2) patients (e.g., consumers, patients), and (3) patient involvement (e.g., patient participation). Searches were limited to the English language as terminology regarding low-value care (e.g., Choosing Wisely, low-value, overuse, etc.) is unique to the English language and may not translate well across languages. Reference lists of included studies were hand-searched to identify additional citations, and suggestions were provided from experts in the field. Table 1MEDLINE (Ovid) search strategyLine numberSearch terms1health services misuse/or medical overuse/2Unnecessary Procedures/3((misuse\* or overuse\* or unnecessary or ineffective or overtreat\* or overdiagnos\* or overutilis\* or overutiliz\* or low value or waste\*) adj5 (health or healthcare or care or procedure\* or intervention\* or test\* or treatment\*)).tw,kf.4((abandon\* or contradict\* or refute\* or refuting or reassess\* or re-assess\* or obsole\* or revers\* or delist\* or de-list\* or disinvest\* or dis-invest\* or discontinu\* or dis-continu\* or decommission\* or de-commission\* or deadopt\* or de-adopt\* or de-implement\* or deimplement\*) adj5 (medical or health or healthcare or policy or procedure\* or intervention\*)).tw,kf.51 or 2 or 3 or 46patient participation/or community participation/7patient satisfaction/or patient preference/8((patient\* or family\* or families or public or citizen\* or consumer\*) adj5 (perception\* or engag\* or involv\* or participat\* or decision\* or interaction\* or role\* or aware\* or conversation\* or responsibilit\* or discuss\*)).tw,kf.96 or 7 or 8105 and 911choosing wisely.mp.1210 or 1113Limit 12 to English language

Article eligibility and selection {#Sec5}
---------------------------------

Detailed inclusion and exclusion criteria are presented in Table [2](#Tab2){ref-type="table"}. We used Elshaug's definition of low-value care \[[@CR1]\], which was operationalized to include clinical interventions (tests or treatments) that lack efficacy, have risks that outweigh benefits, or are not cost-effective. Citations were screened for inclusion in two phases. Prior to screening, the citation screening form was pilot tested using a random sample of 50 citations and refined until agreement was consistent (*k* \> 0.8). In phase 1, two investigators (EES and CD) screened citations by title and abstract to determine potential eligibility. Potentially relevant citations entered into phase 2 screening where two investigators (EES and LWB) screened full-text versions of each citation to determine eligibility for inclusion. The kappa statistic was used to quantify agreement throughout screening \[[@CR23]\]. Table 2Inclusion and exclusion criteriaInclusion criteriaExclusion criteria**Systematic review** Written in EnglishReported an intervention to reduce low-value care that solely targeted clinicians Described an intervention that engaged patients in their aim to reduce the use of low-value care\*Low-value practice of interest was not a medical test or treatment (e.g., bed rest, use of physical restraints) Used experimental (e.g., randomized clinical trial) or quasi-experimental (e.g., controlled before-and-after study) study designs Reported the use of low-value care with or without the intervention**Meta-analysis** Measured the use of low-value care as the proportion of patients that received the low-value practice with and without exposure to the de-implementation intervention\*Low-value care was defined as a clinical intervention that lacks efficacy, has risks that outweigh benefits, or is not cost-effective \[[@CR1]\]

Data extraction and risk of bias assessment {#Sec6}
-------------------------------------------

Data extraction was conducted in duplicate by three investigators (EES, CD, LWB) in DistillerSR (Evidence Partners, Ottawa, Canada). Our data extraction form was pilot tested using six randomly selected citations. Extracted data pertained to study characteristics (e.g., study design, country of origin), characteristics of the low-value intervention (e.g., test or treatment), components of the intervention (e.g., strategy for patient engagement, clinical setting), and outcomes (e.g., proportion of patients receiving low-value care).

Quality assessment was conducted in duplicate by two investigators (EES and LWB) using the Cochrane Risk of Bias Tool \[[@CR24]\] for the RCTs and a modified Downs and Black checklist for the quasi-experimental studies \[[@CR25]\]. For RCTs, summary assessments did not consider the "Performance Bias" domain, as participants were unable to be blinded due to the behavioral nature of the interventions. The Downs and Black checklist was modified by removing questions pertaining to randomization and control groups as necessary. Question 27 originally had six scoring options based on the percent change a sample was powered to detect, but was modified to "Did the authors conduct a power calculation? 1 = Yes, 0 = No" for simplicity. Due to these modifications, the checklist was scored out of 24, or 25 depending on the design of the study. Percent of the total possible score was calculated for each study to facilitate between-study comparisons. Studies were classified by three categories, which were determined by calculating the median percentage score and assigning scores below and above the median to the "lower quality" and "higher quality" categories, respectively. "Average quality" studies had overall percentage scores equivalent to the median.

Data synthesis and analysis {#Sec7}
---------------------------

The primary outcome was the proportion of patients who received a low-value clinical intervention. Individual study estimates of the primary outcome were pooled using the random effects model of DerSimonian and Laird \[[@CR26]\] and reported as a risk ratio (RR). Publication bias was assessed using a funnel plot and Egger's test. Heterogeneity was assessed using the *I*^2^ statistic \[[@CR27]\] and Cochrane *Q* test. Explanations for heterogeneity were sought through stratified analyses and meta-regression. Pre-specified subgroups for stratified analysis included study design (RCTs vs. non-randomized), type of low-value care (test vs. treatment), and risk of bias (low vs. high/unclear). Meta-analyses were conducted using the metan package in Stata (version 14, StataCorp, TX, USA), and statistical significance was set as *P* \< 0.05.

Results {#Sec8}
=======

Study selection {#Sec9}
---------------

Database and gray literature searches yielded 6736 unique citations, from which we reviewed 218 in full text and included 22 in the systematic review. The most common reason for exclusion after full-text review was the lack of reported use of the low-value practice with and without the intervention (Fig. [1](#Fig1){ref-type="fig"}). Of the 22 included studies, 14 reported the change in use of the low-value practice as the proportion of patients who received the low-value practice with and without the intervention, and were included in the meta-analysis. Fig. 1Selection of articles included in the review

Study characteristics {#Sec10}
---------------------

Characteristics of included studies are described in Table [3](#Tab3){ref-type="table"}. Most studies originated from the USA (*n* = 13, 59%), UK (*n* = 4, 18%), and Canada (*n* = 2, 9%). Nine studies were RCTs, and 13 studies were quasi-experimental. The most common type of low-value care was a medical treatment (*n* = 17, 77%). Studies commonly took place in primary care (*n* = 10, 45%), hospital inpatient wards (*n* = 6, 27%), or emergency departments (*n* = 3, 14%). Six studies (27%) focused on pediatric patients and their caregivers, four studies (18%) targeted adult patients, one study (5%) targeted geriatric patients, and 11 studies did not specify a target age group (50%). Studies used one or more of the following strategies for patient engagement: patient-oriented educational materials (*n* = 18, 82%), shared decision-making (*n* = 5, 23%), and media campaigns (*n* = 4, 18%). Three studies (14%) involved patients or the public in the development of intervention materials (e.g., shared decision-making tool, waiting room posters). Table 3Characteristics of the included studies (*n* = 22)Author (year)CountryDesignNumber of patients includedClinical settingLow-value practiceInterventionControlUse of low-value practice with interventionUse of low-value practice without interventionChange in use of the low-value practice**Randomized clinical trials** Macfarlane (2002) \[[@CR28]\]UKNested212Primary careAntibiotics for acute bronchitisInformation leaflet on the natural course of lower respiratory symptoms and the advantage and disadvantages of antibioticsGeneral practitioner provided prompt card for informing patients that there is no indication for antibioticsProportion of patients who used antibiotics, 47%Proportion of patients who used antibiotics, 62%RR 0.76; 95% CI (0.59--0.97) Francis (2009) \[[@CR29]\]UKCluster558Primary careAntibiotic prescribingInteractive booklet on respiratory tract infectionsUsual careProportion of patients prescribed antibiotics, 19.5%Proportion of patients prescribed antibiotics, 40.8%RR 0.48; 95% CI (0.36, 0.64) Legare (2012) \[[@CR30]\]CanadaCluster181Primary careAntibiotics for acute respiratory tract infectionsShared decision-making between patient and physiciansUsual carePatients who used antibiotics following consultation, 27.2%Patients who used antibiotics following consultation, 52.2%RR 0.53; 95% CI (0.40, 0.70) Tannenbaum (2014) \[[@CR31]\]CanadaCluster303Community pharmacyBenzodiazepines for older adultsBooklet providing information about risks, a tapering protocol, and prompt to discuss with physicianUsual careProportion of patients who discontinued benzodiazepine use, 27.0%Proportion of patients who discontinued benzodiazepine use, 4.5%RR 0.76; 95% CI (0.69, 0.85) Schneiderman (2003) \[[@CR32]\]USAMulti-center551HospitalNon-beneficial life-sustaining treatments in the intensive care unitEthics consultationsUsual careMean (SD) days receiving ventilation, 6.52 (8.52)Mean (SD) days receiving ventilation, 8.22 (11.16)Absolute difference, 1.7 days; *P* = 0.03 Montgomery (2007) \[[@CR33]\]UKThree-armed742HospitalNon-indicated cesarean sectionInformation program: Information about probabilities of clinical outcomesDecision analysis: Decision tree recommended a "preferred option" based on women's preferences and valuesUsual careProportion of elective cesarean sections: information program, 49%; decision analysis, 41%Proportion of elective cesarean sections, 50%Information program:RR 0.95; 95% CI (0.79, 1.14)Decision analysis:RR 0.80; 95% CI (0.66, 0.98) Hess (2012) \[[@CR34]\]USATwo-armed, parallel204Emergency departmentCardiac stress testing in patients at low risk for acute coronary syndromeDecision aid to improve patient knowledge and engage in shared decision-makingUsual careProportion of patients who received stress testing within 30 days of ED visit, 75%Proportion of patients who received stress testing within 30 days of ED visit, 91%RR 0.81; 95% CI (0.72, 0.93) Hess (2016) \[[@CR35]\]USAMulti-center898Emergency departmentCardiac stress testing in patients at low risk for acute coronary syndromeInform patients about their risk and options for care; shared decision aidUsual careProportion of patients who received stress testing within 30 days of ED visit, 38.1%Proportion of patients who received stress testing within 30 days of ED visit, 45.6%RR 0.84; 95% CI (0.72, 0.98) Navaee (2015)IranTwo-armed, parallel67HospitalCesarean section in primiparous womenRole-playing session about the advantages and disadvantages of cesarean sectionUsual careProportion of patients who had a c-section, 2.9%Proportion of patients who had a c-section, 15.6%RR 0.18; 95% CI (0.02--1.48)**Non-randomized intervention studies** Wheeler (2001) \[[@CR36]\]USAProspective observational study144Primary careAntibiotic overuseEducational videotape and written materialsNo control groupProportion of patients receiving antibiotic prescriptions, 4.2%Proportion of patients receiving antibiotic prescriptions, 6.8%RR 0.62; 95% CI (0.15, 2.49) Perz (2002) \[[@CR37]\]USABefore-and-after\*NRPrimary careAntibiotic overuseEducational materials for parents of young children and the general publicUsual carePercent change in antibiotic prescription rate from baseline per 100 person-years, − 19%Percent change in antibiotic prescription rate from baseline per 100 person-years, − 8%Intervention-attributable decline, 11%; 95% CI (8--14%) Dollman (2005) \[[@CR38]\]AustraliaBefore-and-after\~ 20,000Primary careAntibiotic use for upper respiratory tract infections, sinusitis, and otitis mediaPamphlets highlighting risks and benefits distributed to general practices and within the communityNo control groupDefined daily dosages per 1000 population per day, 52.9Defined daily dosages per 1000 population per day, 77.1Overall reduction, 32%; *p* \< 0.01 Gonzales (2005) \[[@CR39]\]USANon-randomized controlled trial\*1144Primary careAntibiotics for children with pharyngitis, antibiotics for adults with acute bronchitisEducational materials mailed to households and available in physicians' officesUsual careProportion of patients prescribed antibiotics:adult, 36%; child, 30%Proportion of patients prescribed antibiotics: adult, 60%; child, 34%Adult:RR 0.60; 95% CI (0.51, 0.70)Child:RR 0.88;95% CI (0.65, 1.18) Ashe (2006) \[[@CR40]\]USABefore-and-after720Primary careAntibiotic overuseEducational waiting room poster in physicians' officesHistorical controls; usual careProportion of patients treated with antibiotics, 48.3%Proportion of patients treated with antibiotics, 44.3%RR 1.09; 95% CI (0.91, 1.31) Gonzales (2008) \[[@CR41]\]USANon-randomized controlled trial992Primary careAntibiotic overuseMedia campaignCounties that did not receive a media campaignNet antibiotic prescriptions per 1000 persons compared to comparison community (12 months post-intervention), − 5Net antibiotic prescriptions per 1000 persons compared to control community (10 months pre-intervention), −18.8% net decrease in managed care-associated antibiotic dispenses per 1000 members; *P* = 0.03 Hemo (2009) \[[@CR42]\]IsraelProspective observational study\*84,979Not specifiedAntibiotic use for upper respiratory tract infection, otitis media, pharyngitisMedia campaignNo control groupPost-campaign period vs. baseline:URI OR 0.749 (0.694, 0.808); otitis media OR 0.652 (0.591, 0.718); pharyngitis OR 0.931 (0.890, 0.973)Pre-campaign period vs. baseline:URI OR 0.962 (0.891, 1.039); otitis media OR 0.970 (0.874, 1.076); pharyngitis OR 0.968 (0.929, 1.009) Morgan (2002) \[[@CR43]\]UKBefore-and-after242Primary careLong-term use of benzodiazepinesPatient letter explaining risks, encouraging a reduction in intake, and prompt to contact physician for discussionNo control groupMean defined daily dosages/patient, 283.0Mean defined daily dosages/patient, 336.6Absolute difference, 53.6; *P* \< 0.001 Simpson (2010) \[[@CR44]\]USABefore-and-after531HospitalElective labor inductionEducational classes on elective induction riskNo educational classesProportion of patients who received elective induction, 27.9%Proportion of patients who received elective induction, 37%RR 0.75; 95% CI (0.58, 0.96) Engineer (2018) \[[@CR45]\]USAQuality improvement project176Emergency departmentComputed tomography for mild head injuryElectronic tool that involved a structured discussion between providers and caregiversNo control groupProportion of patients who received head CT, 22.0%Baseline head CT utilization in the pediatric ED population, 62.7%RR 0.35; 95% CI (0.26, 0.47) Arterburn (2006)USABefore-and-after9515HospitalUnnecessary surgery for knee and hip osteoarthritisPatient decision aids in DVD, website, and booklet formatNo control groupTotal hip replacement per 180 person-days, 0.34Total knee replacement per 180 person-days, 0.09Total hip replacement per 180 person-days, 0.46Total knee replacement per 180 person-days, 0.16Hip replacement relative rate, 0.74, *P* \< 0.01Knee replacement relative rate, 0.62, *P* \< 0.01 Jerardi (2013)USAQuality improvement project224HospitalVoiding cystourethrogram (VCUG) in children with first UTI with normal renal and bladder ultrasound (RBUS)Educational materials and information sheets for patients and familiesNo control groupProportion of patients with normal RBUS who received VCUG: 25.4%Proportion of patients with normal RBUS who received VCUG: 84.9%RR 0.29; 95% CI (0.17, 0.51) Pugel (2018)USAQuality improvement projectHospitalComplete blood counts (CBCs), electrocardiograms (EKGs) as routine screening tests in physical examination visits, age-inappropriate dual-energy absorptiometry (DEXA) scans, imaging for uncomplicated headachePatient-targeted materials produced by Consumer Reports, including exam room posters, patient education materials in waiting areas and exam roomsNo control groupCBCs, 3.16%; EKGs, 0.33%; DEXA scans, 2.02%; imaging for uncomplicated headache, 6.88%CBCs, 42.7%; EKGs, 15.9%; DEXA scans, 25.4%; imaging for uncomplicated headache, 10.8%Absolute difference (95% CI): CBCs 39.54% (39.0--40.0); EKGs 15.57% (15.1--15.8); DEXA scans 23.38% (22.5--24.5); imaging for uncomplicated headache 3.92% (3.3--4.6)*CT* computed tomography, *RR* risk ratio, *ED* emergency department, *SD* standard deviation, *URI* upper respiratory infection\*Adequately adjusted for confounding

The effect of de-implementation interventions that engage patients on the use of low-value care {#Sec11}
-----------------------------------------------------------------------------------------------

Of the 22 included studies, 19 (86%) reported a statistically significant decrease in the use of the targeted low-value practice (Table [3](#Tab3){ref-type="table"}). Low-value treatments were targeted in 17 interventions (77%), of which 12 targeted low-value medications. All but one of these interventions included a patient-targeted education component; six interventions used patient-targeted education exclusively \[[@CR28], [@CR31], [@CR36], [@CR39], [@CR40], [@CR43]\], one intervention supplemented patient-targeted education with shared decision-making \[[@CR29]\], and two interventions used both patient-targeted education and media campaigns \[[@CR37], [@CR38]\]. One intervention engaged patients solely through shared decision-making \[[@CR30]\]. All but two \[[@CR36], [@CR40]\] of these interventions targeting low-value medication reported decreases in the proportion of patients using the medication, ranging from 15 to 25%. However, in one intervention, medication use was reduced in adults (absolute difference 24%, *P* \< 0.02), but not in children (absolute difference 4%, *P* = 0.18) \[[@CR39]\]. Media campaigns were the sole patient-engagement strategy in two interventions \[[@CR41], [@CR42]\], both of which reported a significant reduction in low-value medication use. Further details on the strategies used in these interventions are reported in Table [3](#Tab3){ref-type="table"}.

Targeted low-value procedures included non-indicated cesarean sections \[[@CR33], [@CR46]\], elective labor induction \[[@CR44]\], unnecessary surgery for knee and hip osteoarthritis \[[@CR47]\], and non-beneficial life-sustaining treatments in the intensive care unit (Table [3](#Tab3){ref-type="table"}) \[[@CR32]\]. One study aiming to reduce non-indicated cesarean sections designed two interventions, an informational program and a guided decision analysis, of which only the guided decision analysis was effective \[[@CR33]\]. Elective labor inductions and non-beneficial life-sustaining treatments were successfully reduced through educational classes and ethics consultations, respectively. Unnecessary surgery for hip and knee osteoarthritis was successfully reduced through the use of patient education and decision aids.

Low-value diagnostic tests were targeted in five interventions which reduced use by 7.5--40.7% \[[@CR34], [@CR35], [@CR45], [@CR48], [@CR49]\]; one study reduced the use of computed tomography (CT) scans for mild head injury in children \[[@CR45]\], one study reduced voiding cystourethrograms for children with normal renal and bladder ultrasounds \[[@CR49]\], two studies reduced cardiac stress testing in adults at low risk for acute coronary syndrome, and one study reduced the use of screening tests commonly ordered in physical examination visits such as complete blood counts (CBCs) and electrocardiograms (EKGs) \[[@CR34], [@CR35], [@CR48]\]. Of these five interventions, three studies took place within an emergency department and used shared decision-making. Four of the studies included educational materials to inform patients about risks and care options \[[@CR34], [@CR35]\].

Fourteen studies inclusive of 10,234 patients were included in the meta-analysis. Pooling data indicated that de-implementation interventions that engage patients within the patient-clinician interaction decreased the use of low-value care by 31% (RR 0.69; 95% CI 0.60--0.80; *I*^2^ 84.9%) (Fig. [2](#Fig2){ref-type="fig"}). This effect was similar in RCTs (*n* = 8 studies, 3537 patients) (RR 0.74; 95% CI 0.66--0.84; *I*^2^ 70.7%) and quasi-experimental studies (*n* = 6 studies, 6697 patients) (RR 0.61; 95% CI 0.43--0.87; *I*^2^ 90.9%) (Fig. [2](#Fig2){ref-type="fig"}). Egger's test (*p* = 0.201) and assessment of the funnel plot (Fig. [3](#Fig3){ref-type="fig"}) for asymmetry indicated a lack of publication bias. Fig. 2Random effects meta-analysis stratified by study design examining the effect of de-implementation interventions that engage patients within the patient-clinician interaction on the use of low-value careFig. 3Funnel plot with pseudo 95% CIs

Quality assessment {#Sec12}
------------------

### Randomized clinical trials {#Sec13}

Of eight RCTs, five had an overall low risk of bias \[[@CR29]--[@CR31], [@CR34], [@CR35]\], three had an overall unclear risk of bias \[[@CR28], [@CR32], [@CR33]\], and one had an overall high risk of bias (Additional File [1](#MOESM1){ref-type="media"}). All but two studies had a low risk of selection bias, and all studies had a low risk of attrition bias. The reporting bias domain was unclear in three studies.

### Quasi-experimental studies {#Sec14}

All quasi-experimental studies clearly reported objectives and interventions; however, potentially confounding variables were poorly reported. Nine studies (69%) aimed to recruit participants that were representative of the source population, and 12 (92%) used staff, places, and facilities that were representative of treatment received by most patients. None of the studies provided sufficient information to determine whether participants were representative of the population from which they were recruited. None of the studies blinded participants or outcome assessors. The median quality score was 57 (IQR 52--66). Five studies above the median were classified as "higher" quality, six studies below the median were classified as "lower" quality, and two studies that were equivalent to the median were classified as "average" quality (Additional File [2](#MOESM2){ref-type="media"}).

Exploration for sources of heterogeneity {#Sec15}
----------------------------------------

Stratified analyses were conducted to explore heterogeneity. Among the five RCTs with low risk of bias, studies used diverse strategies for public engagement and various low-value practices: four studies used shared decision-making, whereas one used patient-targeted educational materials, and three studies targeted medications, whereas two targeted diagnostic tests. Stratification by the strategy for patient engagement suggested that shared decision-making had a greater effect on reducing the use of low-value care (RR 0.58; 95% CI 0.41--0.82; *I*^2^ 92.8%) in comparison (meta-regression *P* = 0.07) to patient-oriented educational materials (RR 0.76; 95% CI 0.65--0.89; *I*^2^ 77.4%) (Fig. [4](#Fig4){ref-type="fig"}). Similar effect sizes were found when the meta-analysis was stratified by studies targeting low-value tests (*n* = 4) (RR 0.54; 95% CI 0.34--0.86; *I*^2^ 94.7%) and low-value treatments (*n* = 10) (RR 0.74; 95% CI 0.64--0.85; *I*^2^ 78.2%) (Fig. [5](#Fig5){ref-type="fig"}). When the meta-analysis was restricted to RCTs with low risk of bias (*n* = 5), the effect of patient-targeted interventions remained significant (RR 0.69; 95% CI 0.58--0.83) although there was still a high degree of heterogeneity (*I*^2^ 81.7%; Q-statistic *P* \< 0.001) (Fig. [6](#Fig6){ref-type="fig"}). Meta-regression, although limited by the small number of studies, suggested that neither variability due to the targeted low-value care (test vs. treatment) nor strategy for patient engagement (shared decision-making vs. patient-oriented educational materials) contributed to inter-study heterogeneity (Additional File [3](#MOESM3){ref-type="media"}). Fig. 4Random effects meta-analysis of the association between patient-targeted interventions to reduce low-value care by the strategy for patient involvementFig. 5Stratified by type of low-value care, random effects meta-analysis examining the effect of de-implementation interventions that engage patients within the patient-clinician interaction on the use of low-value careFig. 6Among RCTs stratified by summary risk of bias assessment, random effects meta-analysis examining the effect of de-implementation interventions that engage patients within the patient-clinician interaction on the use of low-value care

Discussion {#Sec16}
==========

We identified nine RCTs and thirteen quasi-experimental studies that prospectively evaluated the effect of de-implementation interventions that engaged patients within the patient-clinician interaction on the use of low-value care. Compared to a prior knowledge synthesis examining this topic \[[@CR17]\], we identified additional relevant studies and provide a tangible, quantified estimate of the effect of these interventions. Patient engagement occurred through patient-oriented educational materials, mass media campaigns, and shared decision-making between the patient and clinician. Studies examined a broad array of low-value care including potentially unnecessary tests (e.g., computed tomography scans for mild head injuries), treatments (e.g., antibiotics for upper respiratory tract infections), and surgeries (e.g., cesarean sections). The most common clinical context was adult patients making decisions about medical treatments in primary care. Meta-analysis demonstrated that patient engagement within the patient-clinician interaction reduced the use of low-value care by an average of 31% (range 20 to 40%). Although this effect estimate was limited by inter-study heterogeneity, it is the first to quantify the potential impact of such de-implementation interventions, and despite the heterogeneity, effects remained consistent when examined in subgroups defined by different strategies for patient engagement, types of low-value care, and study design. Researchers, policymakers, and decision-makers should consider the patient-targeted intervention as a strategy for reducing low-value care.

Our results add to and compare favorably with prior research examining a similar question \[[@CR17]\]. Colla et al. performed a systematic review examining interventions to reduce low-value care, inclusive of 108 articles, of which 19 reported on interventions that involved a patient education component. Narrative synthesis among the 19 articles concluded that patient-oriented education is an effective strategy for patient engagement within the patient-clinician interaction and can successfully reduce low-value care. However, many of their studies used patient-targeted strategies within multicomponent interventions that included clinician-targeted strategies (e.g., clinical decision support, provider feedback). This makes it challenging to understand which components of the intervention (i.e., patient-targeted or clinician-targeted) were actually effective and whether there is an advantage to focusing on one group or another. Although it would seem logical that the synergistic effects achieved from simultaneously engaging patients and clinicians would be greater than those from strategies engaging the two parties separately, this has yet to be adequately examined. Understanding the effects of patient-targeted interventions is important because clinicians have indicated that important barriers to reducing low-value care include patient care expectations and the risk of patient dissatisfaction if expectations are not met \[[@CR15], [@CR16]\]. Moreover, given the costs and resources associated with multicomponent de-implementation initiatives, understanding which strategies have the greatest effect on reducing low-value care is important for advancing the science of de-implementation and informing how to best reduce low-value care. Patient-targeted interventions within the patient-clinician interaction may help to mitigate these challenges. As clinician-targeted strategies did not meet inclusion criteria for our systematic review, this enabled us to isolate studies that only reported on patient-targeted interventions within the patient-clinician interaction and examine their effect on use of low-value care.

Acknowledging the potential benefits of patient engagement in reducing low-value care, patient engagement in clinical decision-making is often viewed as challenging, time-consuming, and potentially costly \[[@CR50], [@CR51]\]. Our study demonstrates that the ensuant reductions in low-value care make tackling these challenges worthwhile. However, it is important to consider that the nature and success of patient-targeted de-implementation interventions likely depend on patient and clinician characteristics, clinical context, and the targeted low-value practice. For example, one study found that patient-oriented educational materials reduced unnecessary medication use among adult, but not pediatric, patients \[[@CR39]\]. This finding is congruent with and potentially explained by evidence from recent systematic reviews indicating that informational components may be sufficient for interventions that target patients (e.g., adults), but that caregivers (e.g., parents of children) require supplemental information that enables activation (i.e., prompting action) and/or collaboration (i.e., engagement with clinicians or others) \[[@CR52], [@CR53]\]. Because these de-implementation interventions occur within the patient-clinician interaction, their success will also depend on the characteristics of participating clinicians and their ability and intention to engage the patient in strategies like shared decision-making. Interventions may benefit from a training component wherein clinicians learn how to effectively engage patients through the selected strategy. In addition, most interventions in our review targeted low-value practices that lacked efficacy in a primary care setting by providing patients with educational materials. This approach to patient engagement was evidently effective for a low-value practice associated with minimal risk for patients with low illness burden. However, for low-value practices provided to patients with greater illness burden cared for in clinical contexts associated with greater risk (e.g., emergency departments, hospital inpatient wards, etc.), de-implementation interventions that seek to engage patients and/or their caregivers will likely require more interaction and collaboration with clinicians. Although few studies in our review examined patient-focused interventions in high acuity contexts, one study did successfully implement an intervention that involved families and clinicians in ethics consultations to discuss non-beneficial life-sustaining treatments in intensive care units \[[@CR32]\]. Future research should examine the effect of patient engagement on the use of low-value care in acute care contexts.

Strengths and limitations {#Sec17}
-------------------------

A notable strength of this study is the rigorous methodology which included a peer-reviewed search strategy and adherence to published guidelines regarding systematic review and meta-analysis methodology. In addition, our review was narrow in scope and focused solely on de-implementation interventions that engaged patients within the patient-clinician interaction, which is arguably one of the most critical clinical contexts for influencing the use of low-value care. Our meta-analysis quantified the effect of patient engagement within the patient-clinician interaction and confirmed its effectiveness as an approach to reducing low-value care, while highlighting important heterogeneity within published literature. However, this study must be interpreted within the context of its limitations. First, the English language restriction may have omitted relevant articles, yet it is unlikely that this would have altered our main findings. Second, the main outcome of the proportion of patients who received the low-value practice may have overestimated the use of certain low-value practices. For example, if a study's outcome was the number of patients given a prescription for benzodiazepines and some patients did not end up using the prescription, the true number would have been overestimated. However, this misclassification bias is expected to be non-differential and would suggest that if anything, our results are a conservative estimate of the true population effect. Third, this study focused on low-value clinical interventions, and therefore, we cannot comment on the de-implementation of non-medical forms of care. In addition, the majority of included studies targeted medication prescribing in primary care. This limits the generalizability of our results. Further research is needed to determine if the observed effects persist in other clinical contexts (e.g., emergency department). Fourth, there was significant inter-study heterogeneity that affects interpretation of the pooled estimates. Given the nature of our research question, we anticipated observing inter-study heterogeneity within our pooled estimates. We proceeded with calculating pooled effect estimates in spite of this because (1) effect estimates from individual studies, especially those that were of higher quality, were similar; (2) pooled estimates have greater utility relative to individual study effect estimates, as they may be used to facilitate comparisons with meta-analyses of other types of interventions aiming to reduce low-value care (e.g., provider-targeted interventions); (3) collectively, this small group of studies represents the totality of available evidence for evaluating the average impact of patient-targeted interventions on use of low-value care, so restricting our scope to a specific low-value practice, patient population, or patient-engagement tool would have resulted in a small number of studies precluding any meaningful findings; and (4) similar approaches have been employed in other meta-analyses investigating the utility of interventions that span clinician disciplines and patient populations, such as decision aids \[[@CR54]\]. Finally, although this review indicated that de-implementation interventions that engage patients within the patient-clinician interaction is a promising approach for reducing low-value care, we must consider that the implementation and effectiveness of these interventions will be significantly influenced by clinicians, given that they hold the authority to order a low-value test or treatment. This review did not aim to explore how clinicians may respond to or support patient engagement in de-implementation interventions, and therefore, further research is required to determine how to appropriately support and engage clinicians within such interventions.

Conclusions {#Sec18}
===========

This systematic review with meta-analysis suggests that de-implementation interventions that engage patients within the patient-clinician interaction through patient-targeted educational materials or shared decision-making are effective in decreasing the use of low-value care, especially for medical treatments prescribed within primary care. Additional research should seek to understand the utility of patient-targeted interventions in the acute care context and how the effectiveness of patient-targeted interventions compares to that of clinician-targeted or multicomponent interventions. However, based on the results of this study, de-implementation interventions that seek to reduce low-value medical treatments provided to patients in a primary care setting should incorporate patient engagement using tailored educational and shared decision-making tools.
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